Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

J&J Announces Phase 3 Data Showing TREMFYA Delivers Combined Fistula Remission in Crohn's Disease with Perianal Fistula – Only IL‑23 Inhibitor with Dedicated Trial Success
CompanyDrug

J&J Announces Phase 3 Data Showing TREMFYA Delivers Combined Fistula Remission in Crohn’s Disease with Perianal Fistula – Only IL‑23 Inhibitor with Dedicated Trial Success

Johnson & Johnson (J&J, NYSE: JNJ) announced new Phase 3 data showing consistent combined fistula remission outcomes with TREMFYA (guselkumab) across clinically important subgroups of adults with Crohn's disease with…

NHC and NDRC Launch Expansion and Quality Enhancement Plan for Rehabilitation and Nursing Care – 0.48 Beds per 1,000 Population Targeted by 2030

NHC and NDRC Launch Expansion and Quality Enhancement Plan for Rehabilitation and Nursing Care – 0.48 Beds per 1,000 Population Targeted by 2030

Hengrui Wins NMPA Clinical Trial Approval for SHR‑3201 – First‑in‑Class Investigational Therapy Targeting Alzheimer's Disease

Hengrui Wins NMPA Clinical Trial Approval for SHR‑3201 – First‑in‑Class Investigational Therapy Targeting Alzheimer’s Disease

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

HighTide Therapeutics Doses First Patient in Phase IIb Study for HTD1801 in NASH

CompanyDrug

Jiangsu Kanion’s KYS202002A Greenlit for Clinical Study in Multiple Myeloma

CompanyDrug

Innovent Biologics Doses First Patient in Phase III Study for Mazdutide

CompanyDrug

Jiangxi Jemincare’s JMKX003142 Gets FDA Nod for Clinical Study

CompanyDrug

Yantai Dongcheng Pharma Gets FDA Go-Ahead for 177Lu-LNC1004 Clinical Trial

CompanyDrug

Jacobio Pharma Doses First Patient in US Phase I/IIa Study for JAB-2485

CompanyDrug

Dizal’s Sunvozertinib and Golidocitinib Combo Gets NMPA Approval for Phase II Study

CompanyDrug

Luye Pharma’s BA1301 Receives CDE Approval for Clinical Trials

Show More